These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2873591)

  • 1. Effects of amnesic doses of reserpine or syrosingopine on mouse brain acetylcholine levels.
    Palfai T; Wichlinski L; Brown HA; Brown OM
    Pharmacol Biochem Behav; 1986 May; 24(5):1457-9. PubMed ID: 2873591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral catecholamines and memory: characteristics of syrosingopine-induced amnesia.
    Walsh TJ; Palfai T
    Pharmacol Biochem Behav; 1979 Oct; 11(4):449-52. PubMed ID: 42929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of an amnesic dose of reserpine, syrosingopine or guanethidine on the levels of whole brain dopamine and norepinephrine in the mouse.
    Brown OM; Palfai T; Wichlinski L
    Pharmacol Biochem Behav; 1981 Dec; 15(6):911-4. PubMed ID: 6119704
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of tranquilizers on the total acetylcholine content and acetylcholinesterase activity in the brain tissue of Arvicanthis niloticus.
    Fathi MM; Asaad AM
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1985; 82(2):467-74. PubMed ID: 2866923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of reserpine, syrosingopine, and guanethidine on the retention of discriminated escape reversal: peripherally administered catecholamines cannot reverse the reserpine amnesia in this situation.
    Palfai T; Wichlinski L; Brown OM
    Behav Neural Biol; 1983 May; 38(1):120-6. PubMed ID: 6138025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective depleting effect of syrosingopine on brain catecholamine levels with relation to morphine analgesia in the rat.
    Furukawa T; Sano T; Kohno Y; Koga M; Nagasaki N
    Pharmacol Biochem Behav; 1976 Apr; 4(4):419-25. PubMed ID: 6976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of syrosingopine on the acetylcholine content in albino rats.
    Agarwel SL; Bhargava V; Jadhav JH
    Indian J Physiol Pharmacol; 1966 Oct; 10(4):166-7. PubMed ID: 4384035
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of desipramine and reserpine on 'free' and 'bound' acetylcholine in rat brain.
    Hrdina PD; Ling GM
    J Pharm Pharmacol; 1973 Jun; 25(6):504-7. PubMed ID: 4146597
    [No Abstract]   [Full Text] [Related]  

  • 9. Regional brain acetylcholine kinetics: effects of reserpine.
    Finberg JP; Buccafusco JJ; Spector S
    Life Sci; 1979 Jul; 25(2):147-55. PubMed ID: 491841
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of the long-term cumulative effects of reserpine and syrosingopine on general activity.
    Palfai T; Walsh TJ
    Pharmacol Biochem Behav; 1979 Nov; 11(5):585-7. PubMed ID: 43517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of reserpine on the acetylcholine content of the heart, the ileum and the hypothalamus of the dog.
    MALHOTRA CL; DAS PK
    Br J Pharmacol Chemother; 1962 Feb; 18(1):190-3. PubMed ID: 14468899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain acetylcholine levels and inhibition of the tail-flick reflex in mice.
    Howes JF; Harris LS; Dewey WL; Voyda CA
    J Pharmacol Exp Ther; 1969 Sep; 169(1):23-8. PubMed ID: 5804609
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of reserpine on the acetylcholine content of different areas of the central nervous system of the dog.
    MALHOTRA CL; PUNDLIK PG
    Br J Pharmacol Chemother; 1959 Mar; 14(1):46-7. PubMed ID: 13651578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the pharmacology of syrosingopine and reserpine.
    Pham-Huu-Chanh ; De Schaepdryver AF
    Arch Int Pharmacodyn Ther; 1965 Sep; 157(1):207-13. PubMed ID: 4380062
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effects of (-), (+)clausenamide on anisodine-induced acetylcholine decrease and associated memory deficits in the mouse brain].
    Duan W; Zhang J
    Yao Xue Xue Bao; 1998; 33(4):259-63. PubMed ID: 11939064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Memory storage impairment or retrieval failure: pharmacologically distinguishable processes.
    Walsh TJ; Palfai T
    Pharmacol Biochem Behav; 1979 Oct; 11(4):453-6. PubMed ID: 574972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acetylcholine contents and muscarinic receptor levels in frontal cortex, corpus striatum, and hippocampus of reserpinized rats and mice.
    Pan SY
    Zhongguo Yao Li Xue Bao; 1992 May; 13(3):223-6. PubMed ID: 1442103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Actions of reserpine and tyramine on the acetylcholine content of brain stem, heart and blood of the rat.
    Malpica JF; Jurupe H; Campos HA
    Arch Int Pharmacodyn Ther; 1970 May; 185(1):13-9. PubMed ID: 5470014
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of clausenamide on anisodine-induced acetylcholine decrease and memory deficits in the mouse brain.
    Duan W; Zhang J
    Chin Med J (Engl); 1998 Nov; 111(11):1035-8. PubMed ID: 11189211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of drugs on tremor and increase in brain acetylcholine produced by oxotremorine in the rat.
    Cox B; Potkonjak D
    Br J Pharmacol; 1970 Jan; 38(1):171-80. PubMed ID: 5413285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.